Dr. Bruno Carneiro de Medeiros MD
Hematologist-Oncologist | Hematology & Oncology
269 Campus Dr Ccsr 1155 Stanford CA, 94305About
Dr. Bruno Medeiros is a hematologist oncologist practicing in Stanford, CA. Dr. Medeiros specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Education and Training
Federal University of Parana
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM- Hematology- 2006
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 2005
Provider Details
Expert Publications
Data provided by the National Library of Medicine- Second bone marrow transplantation for severe aplastic anemia: analysis of 34 cases.
- [Pilocytic astrocytoma in childhood: presentation of six cases].
- Absence of FTL3 mutations in patients with JAK2V617F mutation negative essential thrombocythemia.
- Chlordiazepoxide for imatinib-induced muscular cramps.
- Presence of t(1;14)(p13;p11.2) in Philadelphia chromosome-negative cells in a patient with chronic myeloid leukemia.
- Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantation.
- Graphium basitruncatum fungemia in a patient with acute leukemia.
- Characteristics and outcomes of acute myelogenous leukemia patients with very late relapse (>5 years).
- Comparing apples and oranges in normal karyotype acute myeloid leukemia.
- Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report.
- Role of CEBPA in normal karyotype acute myeloid leukemia.
- Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
- Molecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remission.
- Thalidomide-induced pneumonitis in a patient with plasma cell leukemia: No recurrence with subsequent lenalidomide therapy.
- Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.
Treatments
- Acute Leukemia, General Care, Cancer
Fellowships
- Acute leukemia, Princess Margaret Hospital - University of Toronto 2006
- University of Colorado Health Science Center CO 2005
- Acute leukemia, Princess Margaret Hospital - University of Toronto 2006
Publications
- Proceedings of the tiol Academy of Sciences of the United States of AmPreleukemic mutations in human acute myeloid leukemia affect epigenetic regulators2014
- BRITISH JOURL OF HAEMATOLOGYUnsuccessful diagnostic cytogenetic alysis is a poor prognostic feature in acute myeloid leukaemia2014
- HaematologicaSequential azacitidine plus lelidomide combition2013
- HAEMATOLOGICA-THE HEMATOLOGY JOURLImpact of body-mass index on the outcome of adult patients with acute myeloid leukemia2012
- LEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lelidomide for2012
- AMERICAN JOURL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
- NEW ENGLAND JOURL OF MEDICINECytarabine Dose for Acute Myeloid Leukemia2011
- Jourl of the tiol Comprehensive Cancer NetworkSenior adult oncology, version 2.2014: clinical practice guidelines in oncology .2014
- HAEMATOLOGICAGemtuzumab ozogamicin in combition with vorinostat2014
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKHematopoietic Stem Cell Transplantation for Hematologic Maligncies in Older Adults2014
- Jourl of oncology practice / American Society of Clinical OncologyQualitative alysis of practicing oncologists' attitudes2013
- Leukemia & lymphomaA single-center experience of the tionwide daunorubicin shortage2013
- Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C.Amrubicin, a Novel Investigatiol Anthracycline0
- Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., MedA Phase I/II Study of Bortezomib0
- HEMATOLOGYHemophagocytic lymphohistiocytosis in pregncy: a case report and review of treatment options2012
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKWaldenstrom's Macroglobulinemia2012
- Jourl of the tiol Comprehensive Cancer NetworkWaldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.2012
- AMERICAN JOURL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
- INTERTIOL JOURL OF HEMATOLOGYNovel agents in acute myeloid leukemia2012
- JOURL OF GERIATRIC ONCOLOGYNew treatment approaches for older adults with multiple myeloma2012
- HAEMATOLOGICA-THE HEMATOLOGY JOURLPhase II trial of vorinostat and gemtuzumab ozogamicin as induction and post2012
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKSenior Adult Oncology2012
- HAEMATOLOGICA-THE HEMATOLOGY JOURLPhase I trial of a novel human monoclol antibody mAb216 in patients with relapsed or refractory B2012
- HAEMATOLOGICA-THE HEMATOLOGY JOURLTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2011
- BRITISH JOURL OF HAEMATOLOGYAcute myeloid leukaemia in the elderly: a review2011
- LAB ON A CHIPMicrofluidic purification and alysis of hematopoietic stem cells from bone marrow2011
- Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., GoA Phase I Study of Sequential Azacitidine2010
- AMERICAN JOURL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
- Expert review of hematologyPlasma cell leukemia: concepts and magement.2010
- EXPERT REVIEW OF HEMATOLOGYPlasma cell leukemia: concepts and magement2010
- AMERICAN JOURL OF HEMATOLOGYMyelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with2010
- Walter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, PHASE 2 TRIAL OF VORINOSTAT2010
- JOURL OF THE TIOL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2009
- AMERICAN JOURL OF HEMATOLOGYThalidomide-induced pneumonitis in a patient with plasma cell leukemia2009
- Jourl of the tiol Comprehensive Cancer NetworkNCCN clinical practice guidelines in oncology: multiple myeloma.2009
- NEW ENGLAND JOURL OF MEDICINEDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia2009
- JOURL OF CLINICAL ONCOLOGYRole of CEBPA in Normal Karyotype Acute Myeloid Leukemia2009
- JOURL OF CLINICAL ONCOLOGYComparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia2009
- Cases jourlComplete remission of primary plasma cell leukemia with bortezomib, doxorubicin2009
- Proceedings of the National Academy of Sciences of the United States oPreleukemic mutations in human acute myeloid leukemia affect epigenetic regulators2014
- BRITISH JOURNAL OF HAEMATOLOGYUnsuccessful diagnostic cytogenetic analysis is a poor prognostic feature2014
- HaematologicaSequential azacitidine plus lenalidomide combination2013
- HAEMATOLOGICA-THE HEMATOLOGY JOURNALImpact of body-mass index on the outcome of adult patients with acute myeloid leukemia2012
- BLOODBlood consult: monosomal karyotype acute myeloid leukemia2012
- LEUKEMIASafety, efficacy and biological predictors of response to sequential azacitidine and lenalidomide2012
- CANCERImpact of residual normal metaphases in core binding factor acute myeloid leukemia2012
- BloodUnveiling the complexity of CK+ AML.2012
- AMERICAN JOURNAL OF HEMATOLOGYTailored temozolomide therapy according to MGMT methylation status2012
- NEW ENGLAND JOURNAL OF MEDICINECytarabine Dose for Acute Myeloid Leukemia2011
- BLOODPrognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia2010
- LEUKEMIA RESEARCHMcl-1 dependence predicts response to vorinostat2014
- Journal of the National Comprehensive Cancer NetworkSenior adult oncology, version 2.2014: clinical practice guidelines in oncology .2014
- Acta haematologicaFacts about FCE (Fludarabine, Cytarabine, Etoposide) in Acute Myeloid Leukemia.2014
- HAEMATOLOGICAGemtuzumab ozogamicin in combination with vorinostat2014
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKHematopoietic Stem Cell Transplantation for Hematologic Malignancies in Older Adults2014
- Journal of oncology practice / American Society of Clinical OncologyQualitative analysis of practicing oncologists' attitudes2013
- Leukemia & lymphomaA single-center experience of the nationwide daunorubicin shortage2013
- LEUKEMIA RESEARCHCD11b expression and MK+ AML: A sign of impending doom?2013
- LEUKEMIA & LYMPHOMA2-Hydroxyglutarate in IDH mutant acute myeloid leukemia2013
- LEUKEMIACD19(-)CD45(low/-)CD38(high)/CD138(+) plasma cells enrich for human tumorigenic myeloma cells2012
- Dinner, S. N., Dunn, T. J., Medeiros, B. C., Coutre, S. E., Berube, C.Amrubicin, a Novel Investigational Anthracycline0
- Becker, P. S., Medeiros, B. C., Stein, A. S., Appelbaum, F. R., Scott,Multicenter Phase 2 Trial of G-CSF Priming, Clofarabine0
- Dunn, T. J., Dinner, S. N., Berube, C., Gotlib, J., Coutre, S. E., MedA Phase I/II Study of Bortezomib0
- HEMATOLOGYHemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options2012
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKWaldenstrom's Macroglobulinemia2012
- Journal of the National Comprehensive Cancer NetworkWaldenström's macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2013.2012
- AMERICAN JOURNAL OF HEMATOLOGYAbsolute lymphocyte count at day 28 independently predicts event-free2012
- INTERNATIONAL JOURNAL OF HEMATOLOGYNovel agents in acute myeloid leukemia2012
- JOURNAL OF GERIATRIC ONCOLOGYNew treatment approaches for older adults with multiple myeloma2012
- HAEMATOLOGICA-THE HEMATOLOGY JOURNALPhase II trial of vorinostat and gemtuzumab ozogamicin as induction and post2012
- APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGYAggressive EBV-associated Lymphoproliferative Disorder2012
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKSenior Adult Oncology2012
- LEUKEMIA RESEARCHIt doesn't matter if you're black or white, does it?2012
- HAEMATOLOGICA-THE HEMATOLOGY JOURNALPhase I trial of a novel human monoclonal antibody mAb216 in patients with relapsed or refractory B2012
- HAEMATOLOGICA-THE HEMATOLOGY JOURNALTreatment advances have not improved the early death rate in acute promyelocytic leukemia2012
- Becker, P. S., Medeiros, B. C., Appelbaum, F. R., Scott, B. L., HendriPhase 2 Trial of G-CSF Priming, Clofarabine2011
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2011
- EXPERT REVIEW OF HEMATOLOGYUnfavorable-risk cytogenetics in acute myeloid leukemia2011
- EXPERT OPINION ON THERAPEUTIC TARGETSTargeting protein neddylation: a novel therapeutic strategy for the treatment of cancer2011
- BRITISH JOURNAL OF HAEMATOLOGYAcute myeloid leukaemia in the elderly: a review2011
- LAB ON A CHIPMicrofluidic purification and analysis of hematopoietic stem cells from bone marrow2011
- Pollyea, D. A., Kohrt, H. E., Gallegos, L., Berube, C., Coutre, S., GoA Phase I Study of Sequential Azacitidine2010
- Medeiros, B. C., Kohrt, H. E., Rajwanshi, R., Gotlib, J., Coutre, S., Temozolomide In Acute Myeloid Leukemia2010
- AMERICAN JOURNAL OF HEMATOLOGYSecond-line mitoxantrone, etoposide2010
- Expert review of hematologyPlasma cell leukemia: concepts and management.2010
- EXPERT REVIEW OF HEMATOLOGYPlasma cell leukemia: concepts and management2010
- AMERICAN JOURNAL OF HEMATOLOGYMyelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with2010
- Walter, B., Medeiros, B., Nielsen-Stoeck, M., Harrington, E., Powell, PHASE 2 TRIAL OF VORINOSTAT2010
- LEUKEMIA RESEARCHImmunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2)2010
- Alizadeh, A. A., McClellan, J. S., Gotlib, J. R., Coutre, S., Majeti, Early Mortality in Acute Promyelocytic Leukemia May Be Higher Than Previously Reported.2009
- Kohrt, H. E., Patel, S., Ho, M., Owen, T., Majeti, R., Gotlib, J. R., Is Time of the Essence in Adult Acute Myeloid Leukemia2009
- JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORKMultiple Myeloma2009
- AMERICAN JOURNAL OF HEMATOLOGYThalidomide-induced pneumonitis in a patient with plasma cell leukemia2009
- Journal of the National Comprehensive Cancer NetworkNCCN clinical practice guidelines in oncology: multiple myeloma.2009
- Medeiros, B. C., Gotlib, J. R., Coutre, S. E., Jones, C., Khan, S. A.,Interim results of protracted low doses of temozolomide in high-risk acute myeloid leukemia0
- NEW ENGLAND JOURNAL OF MEDICINEDeletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia2009
- JOURNAL OF CLINICAL ONCOLOGYRole of CEBPA in Normal Karyotype Acute Myeloid Leukemia2009
- JOURNAL OF CLINICAL ONCOLOGYComparing Apples and Oranges in Normal Karyotype Acute Myeloid Leukemia2009
- McGuire, A., Shier, L. R., Gotlib, J., Medeiros, B., Wong, K., CorlessMyelomastocytic Leukemia: A Clinical, Pathologic, and Molecular Genetic Study2009
- Cases journalComplete remission of primary plasma cell leukemia with bortezomib, doxorubicin2009
Experience & Accolades
- Assistant Professor of Medicine (Hematology)the Stanford University Medical Center
- Panel Member 2007 - 2011Multiple Myeloma Committee, National Comprehensive Cancer Network
- Director 2011 - 2013 Stanford Hospital Hematology Inpatient service
- Director 2009 - 2013 Stanford Acute Leukemia Clinical Research Program
- Panel member 2010 - 2013 adult oncology committee, National comprehensive cancer network
- Acute Leukemia Panel Member 2007 - 2013 Southwest Oncology Group
Dr. Bruno Carneiro de Medeiros MD's Practice location
Dr. Bruno Carneiro de Medeiros MD's reviews
Write ReviewPatient Experience with Dr. Medeiros
Recommended Articles
- Roles of the National Coalition for Cancer Survivorship
The National Coalition for Cancer Survivorship (NCCS) is a nonprofit, cancer advocacy organization that is located just outside of Washington D.C. To date, it is the oldest survivor-led cancer advocacy organization in the United States.The NCCS represents millions of Americans who share a common...
- Make-A-Wish Makes a Movie Star
Through their fundraising, on average in the United States and its territories, Make-A-Wish is able to grant the wish of a child every 34 minutes.How was it started?The Make-A-Wish Foundation started with the wish of one 7-year-old boy’s wish in 1980. Chris Grecius, who had leukemia, wanted to be...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
- Dance Mom Abby Lee Miller Diagnosed with Non-Hodgkin Lymphoma
Abby Lee Miller, known for her brutal dance instruction and demanding style of training, is as recognized for her tirades as she is for her long-running hit reality show Dance Moms.Abby inherited the love of dance from her late mother and started her own dance company at just 14 years old. She...
- Treatment Options of Multiple Myeloma
A team led by a consultant haematology specialist takes care of you if you are a multiple myeloma patient. The team discusses your situation and suggests the best treatment for you, but you will finally decide.It may be paramount to compile a list of questions which you will ask the specialist...
- Morphos Declared a "Breakthrough Therapy" for Lymphoma
MorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
Nearby Providers
- Dr. Joseph Andrew Mollick M.D.875 Blake Wilbur Drive, Mc5820 Stanford CA 94305
- Dr. Saul Rosenberg M.D.269 Campus Dr Stanford CA 94305
- Dr. Alexander Dimitrios Colevas MD875 Blake Wilbur Drive Stanford CA 94305
- Dr. Wen-kai Weng M.D., PH.D.300 Pasteur Dr Stanford CA 94305
- Dr. James M. Ford MD300 Pasteur Dr Stanford CA 94305
- Dr. Arash Ash Alizadeh MD, PHD875 Blake Wilbur Drive Stanford CA 94305